Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C23H23N5O2 |
| Molecular Weight | 401.461 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(CC1=CC=CC=C1)C(=O)CN2C(=O)N(C)C3=C2N=C(N=C3)C4=CC=CC=C4
InChI
InChIKey=NBMBIEOUVBHEBM-UHFFFAOYSA-N
InChI=1S/C23H23N5O2/c1-3-27(15-17-10-6-4-7-11-17)20(29)16-28-22-19(26(2)23(28)30)14-24-21(25-22)18-12-8-5-9-13-18/h4-14H,3,15-16H2,1-2H3
| Molecular Formula | C23H23N5O2 |
| Molecular Weight | 401.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ecnp.eu/~/media/Files/ecnp/Projects%20and%20initiatives/Medicines%20Chest/XBD173.pdfCurator's Comment: description was created based on several sources, including:
http://adisinsight.springer.com/drugs/800013611
https://en.wikipedia.org/wiki/Emapunil
Sources: https://www.ecnp.eu/~/media/Files/ecnp/Projects%20and%20initiatives/Medicines%20Chest/XBD173.pdf
Curator's Comment: description was created based on several sources, including:
http://adisinsight.springer.com/drugs/800013611
https://en.wikipedia.org/wiki/Emapunil
Emapunil acts as a selective agonist at the peripheral benzodiazepine receptor (TSPO). At the cellular level, the selective TSPO ligand XBD173 potentiated the amplitude and duration of GABA-mediated inhibitory postsynaptic currents in mouse medial prefrontal cortical neurons, which was prevented by finasteride. In animal and human trials, XBD173 produced rapid anxiolytic and anti-panic effects probably via newly synthesized neurosteroids, without producing sedation or withdrawal symptoms, and may represent a promising target for the development of fast-acting anxiolytics with a more favourable side-effect profile than benzodiazepines.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL5742 Sources: https://www.ncbi.nlm.nih.gov/pubmed/15249420 |
0.297 nM [Ki] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Synthesis and structure-activity relationship studies in translocator protein ligands based on a pyrazolo[3,4-b]quinoline scaffold. | 2011-10-27 |
|
| Synthesis and evaluation of novel carbon-11 labeled oxopurine analogues for positron emission tomography imaging of translocator protein (18 kDa) in peripheral organs. | 2011-09-08 |
|
| [18F]FEAC and [18F]FEDAC: Two novel positron emission tomography ligands for peripheral-type benzodiazepine receptor in the brain. | 2009-03-15 |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24397957
50uM XBD173 treatment of murine and human microglial cells promoted the formation of filopodia and increased their phagocytic capacity to ingest latex beads or photoreceptor debris. Finally, treatment with XBD173 (20 uM)reversed the amoeboid alerted phenotype of microglial cells in explanted organotypic mouse retinal cultures after challenge with LPS.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:25:37 GMT 2025
by
admin
on
Mon Mar 31 18:25:37 GMT 2025
|
| Record UNII |
OG837L732J
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C28197
Created by
admin on Mon Mar 31 18:25:37 GMT 2025 , Edited by admin on Mon Mar 31 18:25:37 GMT 2025
|
||
|
NCI_THESAURUS |
C29756
Created by
admin on Mon Mar 31 18:25:37 GMT 2025 , Edited by admin on Mon Mar 31 18:25:37 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C82906
Created by
admin on Mon Mar 31 18:25:37 GMT 2025 , Edited by admin on Mon Mar 31 18:25:37 GMT 2025
|
PRIMARY | |||
|
OG837L732J
Created by
admin on Mon Mar 31 18:25:37 GMT 2025 , Edited by admin on Mon Mar 31 18:25:37 GMT 2025
|
PRIMARY | |||
|
CHEMBL513922
Created by
admin on Mon Mar 31 18:25:37 GMT 2025 , Edited by admin on Mon Mar 31 18:25:37 GMT 2025
|
PRIMARY | |||
|
6433109
Created by
admin on Mon Mar 31 18:25:37 GMT 2025 , Edited by admin on Mon Mar 31 18:25:37 GMT 2025
|
PRIMARY | |||
|
DTXSID40177220
Created by
admin on Mon Mar 31 18:25:37 GMT 2025 , Edited by admin on Mon Mar 31 18:25:37 GMT 2025
|
PRIMARY | |||
|
DB12666
Created by
admin on Mon Mar 31 18:25:37 GMT 2025 , Edited by admin on Mon Mar 31 18:25:37 GMT 2025
|
PRIMARY | |||
|
226954-04-7
Created by
admin on Mon Mar 31 18:25:37 GMT 2025 , Edited by admin on Mon Mar 31 18:25:37 GMT 2025
|
PRIMARY | |||
|
100000174972
Created by
admin on Mon Mar 31 18:25:37 GMT 2025 , Edited by admin on Mon Mar 31 18:25:37 GMT 2025
|
PRIMARY | |||
|
8432
Created by
admin on Mon Mar 31 18:25:37 GMT 2025 , Edited by admin on Mon Mar 31 18:25:37 GMT 2025
|
PRIMARY | |||
|
EMAPUNIL
Created by
admin on Mon Mar 31 18:25:37 GMT 2025 , Edited by admin on Mon Mar 31 18:25:37 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET->LIGAND |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|